Kana Lessig Stemsoft - Software

As the industry moves from bench to bedside, the bottleneck often isn't the science—it’s the documentation. The Challenge of Modern Cellular Therapies

The field of cellular therapy is moving at breakneck speed. CAR-T, IEC, and other advanced therapy medicinal products (ATMPs) are revolutionizing patient care, transforming how we treat cancer and other diseases. Yet, with this incredible innovation comes a complex reality: managing the data of human cells as a raw material requires unprecedented precision. Kana Lessig Stemsoft Software

Blog Post: The Future of Cell Therapy Informatics: Ensuring Compliance in an Accelerating Field Date: April 28, 2026 As the industry moves from bench to bedside,